학술논문
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema.
Document Type
Article
Author
Wells, John A.; Glassman, Adam R.; Ayala, Allison R.; Jampol, Lee M.; Aiello, Lloyd Paul; Antoszyk, Andrew N.; Arnold-Bush, Bambi; Baker, Carl W.; Bressler, Neil M.; Browning, David J.; Elman, Michael J.; Ferris, Frederick L.; Friedman, Scott M.; Melia, Michele; Pieramici, Dante J.; Sun, Jennifer K.; Beck, Roy W.
Source
Subject
*EDEMA
*METABOLIC disorder treatment
*BEVACIZUMAB
*VISUAL acuity
*HOSPITAL care
*DIABETIC retinopathy
*
*
*
*
*
Language
ISSN
0028-4793
Abstract
The article discusses research which compared intravitreous aflibercept, bevacizumab and ranibizumab for the treatment of diabetic macular edema. Topics covered include the improvement in the mean visual-acuity letter score of study participants, the lack of significant differences in the rates of adverse events and hospitalization and the efficacy of aflibercept in improving vision.